Bicyclo-pyrazoles active as kinase inhibitors


Ontology type: sgo:Patent     


Patent Info

DATE

2015-04-21T00:00

AUTHORS

Tiziano Bandiera , Jay Aaron Bertrand , Paolo Pevarello , Ettore Perrone , Andrea Lombardi Borgia , Sten Christian Orrenius , Mauro Angiolini , Daniele Fancelli

ABSTRACT

A compound having formula (I): wherein: R, A, R1 and R2, are as defined in the specification, and pharmaceutical formulas thereof, and methods of use thereof, as Kinase inhibitors.

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2581", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Tiziano Bandiera", 
        "type": "Person"
      }, 
      {
        "name": "Jay Aaron Bertrand", 
        "type": "Person"
      }, 
      {
        "name": "Paolo Pevarello", 
        "type": "Person"
      }, 
      {
        "name": "Ettore Perrone", 
        "type": "Person"
      }, 
      {
        "name": "Andrea Lombardi Borgia", 
        "type": "Person"
      }, 
      {
        "name": "Sten Christian Orrenius", 
        "type": "Person"
      }, 
      {
        "name": "Mauro Angiolini", 
        "type": "Person"
      }, 
      {
        "name": "Daniele Fancelli", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1011572610005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047322826", 
          "https://doi.org/10.1023/a:1011572610005"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-04-21T00:00", 
    "description": "

A compound having formula (I): wherein: R, A, R1 and R2, are as defined in the specification, and pharmaceutical formulas thereof, and methods of use thereof, as Kinase inhibitors.

\"embedded

", "id": "sg:patent.US-9012487-B2", "keywords": [ "pyrazole", "kinase inhibitor", "compound", "formula", "wherein", "specification", "pharmaceutical", "method" ], "name": "Bicyclo-pyrazoles active as kinase inhibitors", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.415978.6", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-9012487-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:15", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00998.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-9012487-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-9012487-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-9012487-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-9012487-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

62 TRIPLES      15 PREDICATES      23 URIs      16 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-9012487-B2 schema:about anzsrc-for:2581
2 schema:author N804b2648027345c1acaa012e10018ed2
3 schema:citation sg:pub.10.1023/a:1011572610005
4 schema:datePublished 2015-04-21T00:00
5 schema:description <p id="p-0001" num="0000">A compound having formula (I): wherein: R, A, R<sup>1 </sup>and R<sup>2</sup>, are as defined in the specification, and pharmaceutical formulas thereof, and methods of use thereof, as Kinase inhibitors.</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="31.58mm" wi="69.85mm" file="US09012487-20150421-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif" orientation="portrait" inline="no"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US09012487-20150421-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US09012487-20150421-C00001.MOL"/></attachments></chemistry></p>
6 schema:keywords compound
7 formula
8 kinase inhibitor
9 method
10 pharmaceutical
11 pyrazole
12 specification
13 wherein
14 schema:name Bicyclo-pyrazoles active as kinase inhibitors
15 schema:recipient https://www.grid.ac/institutes/grid.415978.6
16 schema:sameAs https://app.dimensions.ai/details/patent/US-9012487-B2
17 schema:sdDatePublished 2019-04-18T10:15
18 schema:sdLicense https://scigraph.springernature.com/explorer/license/
19 schema:sdPublisher N8a8dd3275f4f4325ad7ff41ea39c5df4
20 sgo:license sg:explorer/license/
21 sgo:sdDataset patents
22 rdf:type sgo:Patent
23 N03f98387afd24d7fbb19fa0e9e149c5f rdf:first N9f279bec90d742fab52900af2e421e79
24 rdf:rest N232f2ea9c2e843ca883b9005ed8ab5de
25 N1e1a2f328df94796aa9bbcf841da37fa rdf:first N6d54afb887ea4637a40a36b4f1a944d4
26 rdf:rest Ne9adcd1723894044931f6f72e713e589
27 N232f2ea9c2e843ca883b9005ed8ab5de rdf:first Nbbdefd3429604de38147760b0a5544d7
28 rdf:rest Nbae9f9f60b3a4ae9858e42dee2e0d680
29 N4ef70e212ce645f38a7cf20c4f1faa00 rdf:first Ne57dc5ccb042450bb5dc102d0938f56d
30 rdf:rest N03f98387afd24d7fbb19fa0e9e149c5f
31 N69bb02e4b13f46c39b63429e8295dc78 schema:name Sten Christian Orrenius
32 rdf:type schema:Person
33 N6d54afb887ea4637a40a36b4f1a944d4 schema:name Mauro Angiolini
34 rdf:type schema:Person
35 N804b2648027345c1acaa012e10018ed2 rdf:first Ncda73df579904be2931867b123d2fbc3
36 rdf:rest N4ef70e212ce645f38a7cf20c4f1faa00
37 N8a8dd3275f4f4325ad7ff41ea39c5df4 schema:name Springer Nature - SN SciGraph project
38 rdf:type schema:Organization
39 N9202f89b15f34915abfa7b1d82bccdfd schema:name Andrea Lombardi Borgia
40 rdf:type schema:Person
41 N9a3590c747ce41d1bd947e78af702c63 schema:name Daniele Fancelli
42 rdf:type schema:Person
43 N9f279bec90d742fab52900af2e421e79 schema:name Paolo Pevarello
44 rdf:type schema:Person
45 Nad7d484bc3c6470f93fe3caec68912d4 rdf:first N69bb02e4b13f46c39b63429e8295dc78
46 rdf:rest N1e1a2f328df94796aa9bbcf841da37fa
47 Nbae9f9f60b3a4ae9858e42dee2e0d680 rdf:first N9202f89b15f34915abfa7b1d82bccdfd
48 rdf:rest Nad7d484bc3c6470f93fe3caec68912d4
49 Nbbdefd3429604de38147760b0a5544d7 schema:name Ettore Perrone
50 rdf:type schema:Person
51 Ncda73df579904be2931867b123d2fbc3 schema:name Tiziano Bandiera
52 rdf:type schema:Person
53 Ne57dc5ccb042450bb5dc102d0938f56d schema:name Jay Aaron Bertrand
54 rdf:type schema:Person
55 Ne9adcd1723894044931f6f72e713e589 rdf:first N9a3590c747ce41d1bd947e78af702c63
56 rdf:rest rdf:nil
57 anzsrc-for:2581 schema:inDefinedTermSet anzsrc-for:
58 rdf:type schema:DefinedTerm
59 sg:pub.10.1023/a:1011572610005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047322826
60 https://doi.org/10.1023/a:1011572610005
61 rdf:type schema:CreativeWork
62 https://www.grid.ac/institutes/grid.415978.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...